CD44 and neoplasm: This result is consistent with the fact that in humans, the population isolated from the primary tumor comprising CD133+/CD44+/CD26+ cells (and E-cadherinlow or E-cadherin−) is not the only CSC population present in the tumor biopsies (Pang et al., 2010).